Relacorilant plus chemo improves PFS and OS vs chemo alone in platinum-resistant ovarian cancer

Barriers to global oncology clinical trial participation in sub-Saharan Africa

Social determinants and survival outcomes in early-onset colorectal cancer in the US

Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers should induce testing guideline reform

Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy

GLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related cancers for diabetics

QoL improvements ID'd in phase 3 ARANOTE trial for mHSPC

Trastuzumab deruxtecan plus pertuzumab may delay cancer growth for some HER2-positive advanced breast cancers

Rusfertide shows promise for polycythemia vera treatment

Neoadjuvant gemcitabine and cisplatin improves OS in resectable biliary tract cancer

Cemiplimab reduces disease recurrence as adjuvant therapy for cutaneous squamous cell carcinoma

ASCO 2025: Update on blood-based cancer assays